- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04042636
Epidemiologic Patterns of Bacteremia After Trauma
Epidemiological Patterns for Early Onset and Late Onset Bacteremia After Trauma
Study Overview
Status
Conditions
Detailed Description
Purpose: Bacteremia is a major nosocomial infection problem in view of its high mortality. Bacteremia occurs in trauma patients frequently and increases a morbidity and mortality. The aim of this study was to identify risk factors and to describe epidemiological patterns for early onset (EOB) and late onset (LOB) bacteremia after trauma.
Methods: All trauma patients admitted to surgical intensive care unit (SICU) and general ward (GW) from January 2011 to December 2015 were retrospectively enrolled. The following information was collected for each patient and recorded in a computer database: demography, severity of trauma according to the Injury Severity Score (ISS) and each abbreviated injury score (AIS), severity of coma according to the Glasgow Coma Scale (GCS), presence of shock and transfusion. Early onset bacteremia was defined as EOB when onset occurred within 7 days after trauma, and late onset bacteremia was defined as LOB when appearing after 7 days from trauma.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of
- Hakjae Lee
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The patients who admitted to intensive care unit (ICU) or general ward (GW) through the emergency department after trauma were studied
Exclusion Criteria:
- Patients who arrived on dead-on arrival
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
1
Patients with Bacteremia after trauma
|
|
2
Patients with non-bacteremia after trauma
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk factor for bacteremia after trauma
Time Frame: 5 years
|
finding fisk factor for bacteremia in traumatic patients
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Etiology of bacteremia after trauma
Time Frame: 5 years
|
distinguishing G(+) cocci, G(-) rod, and candida spp.
|
5 years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Rello J, Ricart M, Mirelis B, Quintana E, Gurgui M, Net A, Prats G. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med. 1994;20(2):94-8. doi: 10.1007/BF01707661.
- Antonelli M, Moro ML, D'Errico RR, Conti G, Bufi M, Gasparetto A. Early and late onset bacteremia have different risk factors in trauma patients. Intensive Care Med. 1996 Aug;22(8):735-41. doi: 10.1007/BF01709514.
- Menges P, Kessler W, Kloecker C, Feuerherd M, Gaubert S, Diedrich S, van der Linde J, Hegenbart A, Busemann A, Traeger T, Cziupka K, Heidecke CD, Maier S. Surgical trauma and postoperative immune dysfunction. Eur Surg Res. 2012;48(4):180-6. doi: 10.1159/000338196. Epub 2012 May 25.
- Niven DJ, Fick GH, Kirkpatrick AW, Grant V, Laupland KB. Cost and outcomes of nosocomial bloodstream infections complicating major traumatic injury. J Hosp Infect. 2010 Dec;76(4):296-9. doi: 10.1016/j.jhin.2010.06.004. Epub 2010 Aug 11.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AsanMC-Bacteremia
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bacteremia
-
University Hospital, Strasbourg, FranceRecruiting
-
West Virginia UniversityEnrolling by invitationStaphylococcus Aureus BacteremiaUnited States
-
Armata Pharmaceuticals, Inc.United States Department of DefenseCompletedBacteremia | Staphylococcus Aureus | Staphylococcus Aureus Bacteremia | Bacteremia Due to Staphylococcus Aureus | Bacteremia StaphUnited States, Australia
-
Osijek University HospitalCompletedSepsis | Gram-negative Bacteremia | Gram-Positive BacteremiaCroatia
-
Intermountain Health Care, Inc.Not yet recruitingStaphylococcus Aureus BacteremiaUnited States
-
Rabin Medical CenterCompletedGram Negative BacteremiaIsrael, Italy
-
Duke UniversityMerck Sharp & Dohme LLCCompletedBacteremia | Gram-negative BacteremiaUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingGram-negative Bacteremia | Intensive Care Patients
-
Singapore General HospitalSingapore Clinical Research InstituteTerminatedBacteremia Due to Staphylococcus AureusSingapore
-
The First Affiliated Hospital of Xinxiang Medical...RecruitingSalmonella BacteremiaChina